News

GenSight Biologics, a biopharma company that discovers and develops innovative gene therapies for neurodegenerative retinal diseases and diseases of the central nervous system,…
Read More...

Ipsen announces that it has signed an agreement to take an equity stake in Akkadeas Pharma with an option to take control of the company in the future. Akkadeas Pharma is a…
Read More...

Noxopharm announces that it has entered into a research agreement with the University of Hong Kong to conduct research into the use of the drug idronoxil (NOX66 active ingredient) to…
Read More...

Medical researchers and IBM are asking for the public's help in identifying prospective treatments for childhood cancers. Scientists are searching for chemical drug candidates that…
Read More...

Every year, Gerresheimer’s pharmaceutical industry customers order several hundreds of millions of glass pharmaceutical packaging products manufactured at the company’s plants in Essen…
Read More...

Astellas Pharma Inc. and Ironwood Pharmaceuticals, Inc. announced top-line results indicating that the Phase III clinical trial of linaclotide conducted in Japan in adults with chronic…
Read More...

Endo International plc announced that one of its operating companies, Par Pharmaceutical has received final approval from the U.S. Food and Drug Administration for its New Drug…
Read More...

Ferring Pharmaceuticals and Enteris BioPharma, Inc. announced that the companies have entered into a license agreement and initiated an early development agreement to leverage Enteris'…
Read More...

Mallinckrodt plc announced that it has entered into an agreement under which it will sell its Intrathecal Therapy business to Piramal Enterprises Limited's subsidiary in the U.K.,…
Read More...

Sanofi announced the appointment of Kathleen Tregoning as member of Executive committee, effective February 27, 2017. Ms. Tregoning will lead Sanofi’s External Affairs organization…
Read More...

uniQure announced that AMT-060,  its proprietary, investigational gene therapy in patients with severe hemophilia B, has received Breakthrough Therapy designation by the U.S. Food and…
Read More...

Mallinckrodt plc, a leading specialty pharmaceutical company, announced that it has closed the sale of its global Nuclear Imaging business to IBA Molecular (IBAM) for approximately $690…
Read More...

FDA has granted orphan drug designation for Vicore Pharma's drug candidates C21 for the treatment of IPF. C21 is thereby approved as an orphan drug in the USA. The approval brings C21…
Read More...

Crown Bioscience, a wholly-owned subsidiary of Crown Bioscience International, and a global drug discovery and development services company providing translational platforms to advance…
Read More...

Medtronic plc (MDT) announced receipt of an investigational device exemption (IDE) from the U.S. Food and Drug Administration (FDA) to initiate a study of the IN.PACT Admiral…
Read More...

H. Lundbeck is partnering with IBM's Watson Health to sped up the development of new medicines for the treatment of psychiatric and neurological disorders. The collaboration will…
Read More...

Biocon Ltd, Asia's premier biopharmaceuticals company, announced that the Ministry of Health (MoH), Malaysia, has awarded a three year contract, to its subsidiary, Biocon SDN. BHD.,…
Read More...

Five Prime Therapeutics, Inc. announced that the European Commission has granted orphan designation for cabiralizumab (FPA008) for the treatment of tenosynovial giant cell tumour,…
Read More...

uniQure announced the appointment of Alexander Kuta, Ph.D., as Senior Vice President of Regulatory Affairs. Dr. Kuta has more than 25 years of regulatory experience within the industry,…
Read More...

Abzena has entered into a licensing agreement with with a San Diego-based biopharmaceutical firm for its novel site-specific ThioBridge antibody drug conjugate (ADC) linker technology.…
Read More...